- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
TAGRISSO - 80mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EB04 | B | Osimertinib - 80mg | 8836 | 117816/1 | TAGRISSO | 80mg | 30 | Tablet, film coated | Oral | Omnipharma | AstraZeneca AB | Sweden | 603,192,941 L.L | 2.44 | E2 | AstraZeneca AB | Sweden | 2/5/2024 | 0 |